Clinical Trials Directory

Autologous Bone Marrow Transplantation for Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission

Evaluate the role of high dose chemotherapy with autologous hematopoietic cell transplantation for AML.

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.



  • procedure : high dose chemotherapy then autologous hematopoietic cell transplant

Phase: Phase 2


Ages Eligible For Study:

16 Years - 69 Years

Inclusion Criteria

- must be in remission - adequate organ function

External Links

Explore related trials

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
BMT Referrals
Not Recruiting

Footer Links: